Belfast, United Kingdom

Chirag Harsharan Singh Gujral

This inventor holds 1 USPTO granted patent. Top assignee: The University of Toyama. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chirag Harsharan Singh Gujral. Retrieved from https://idiyas.com/inventor/chirag-harsharan-singh-gujral

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chirag Harsharan Singh Gujral: Innovator in Controlled Release Technology

Introduction

Chirag Harsharan Singh Gujral is a notable inventor based in Belfast, GB. He has made significant contributions to the field of controlled release technology. His innovative work focuses on the development of compositions that can effectively release physiologically active substances in a controlled manner.

Latest Patents

Chirag holds a patent for a "Composition for controlled release of physiologically active substance." This composition is designed to release a physiologically active substance in vivo at the desired timing. It consists of an inner layer made from a biodegradable substance that supports the active substance, and an outer layer formed from a different biodegradable substance.

Career Highlights

Chirag is affiliated with the University of Toyama, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in various medical and pharmaceutical contexts.

Collaborations

Chirag has collaborated with esteemed colleagues, including Hiromi Kitano and Tadashi Nakaji. Their combined expertise contributes to the advancement of research in controlled release systems.

Conclusion

Chirag Harsharan Singh Gujral is a pioneering inventor whose work in controlled release technology holds promise for future medical applications. His contributions are significant in the ongoing development of innovative solutions in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…